Peripheral Embolization Coils

Global Peripheral Embolization Coils Market to Reach US$533.9 Million by 2030

The global market for Peripheral Embolization Coils estimated at US$439.1 Million in the year 2024, is expected to reach US$533.9 Million by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Detachable Coil Type, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$337.8 Million by the end of the analysis period. Growth in the Pushable Coil Type segment is estimated at 2.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$119.6 Million While China is Forecast to Grow at 6.4% CAGR

The Peripheral Embolization Coils market in the U.S. is estimated at US$119.6 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$106.8 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Peripheral Embolization Coils Market - Key Trends & Drivers Summarized

Why Are Peripheral Embolization Coils Essential in Vascular Care?

Peripheral embolization coils are devices designed to induce vessel occlusion by promoting clot formation at targeted vascular sites. These coils are delivered via catheter into arteries or veins to block abnormal blood flow in conditions such as arteriovenous malformations, aneurysms, trauma-induced hemorrhages, and tumor-related hypervascularity. By enabling localized treatment without open surgery, coils support minimally invasive management of various peripheral vascular disorders.

The coils are manufactured using platinum, stainless steel, or shape-memory alloys, and come in different configurations—pushable, detachable, and complex helical designs—to suit varied anatomical and clinical needs. Their mechanical properties, radiopacity, and deployment control significantly influence treatment outcomes. Increased availability of soft, complex-shaped coils improves conformance within tortuous vessels, reducing procedural complications.

How Are Coil Designs Improving Therapeutic Precision and Safety?

Technological innovation in coil engineering focuses on deliverability, packing density, and thrombotic efficacy. Detachable coil systems allow interventionalists to reposition coils before final deployment, improving accuracy. Microcoils and soft-tip configurations are optimized for distal or fragile vessels. Development of bioactive coatings and fibered variants enhances thrombogenesis, allowing for faster and more secure occlusion in both high-flow and low-flow settings.

Hybrid coil systems combining mechanical and bioactive features are gaining use in complex procedures where single-mechanism coils are insufficient. Compatibility with microcatheters, low-profile systems, and increased visibility under fluoroscopy enhance procedural control and reduce the need for repeat embolizations. Physicians increasingly select coil combinations based on location, blood flow rate, and vessel morphology.

Where Is Adoption Expanding and Which Clinical Areas Lead Use?

Peripheral embolization coils are widely used in interventional radiology, vascular surgery, and oncology. Hemorrhage control, visceral aneurysm management, and preoperative tumor embolization are among the most common applications. The technique is favored in trauma care and gastrointestinal bleeding, where rapid occlusion is needed with minimal procedural risk.

Hospitals and outpatient centers with image-guided intervention capabilities are leading in adoption. Demand is rising across both developed and emerging regions due to expanding access to interventional procedures. Training in minimally invasive therapies and availability of hybrid operating suites are enabling wider coil use in peripheral vascular disease management and targeted oncological interventions.

Growth in the Peripheral Embolization Coils market is driven by several factors…

Growth in the peripheral embolization coils market is driven by rising incidence of peripheral vascular conditions such as aneurysms, arteriovenous malformations, and traumatic bleeds, along with expanding use of minimally invasive therapies. Advancements in coil architecture, including softer materials, enhanced packing designs, and fibered thrombogenic surfaces, are supporting more efficient vessel occlusion.

Improved access to image-guided endovascular suites, growing clinical preference for catheter-based occlusion over surgical ligation, and wider adoption in oncology-related embolization procedures are contributing to demand. Development of microcatheter-compatible systems for distal access and broader clinical training in embolotherapy techniques are further accelerating market growth.

SCOPE OF STUDY:

The report analyzes the Peripheral Embolization Coils market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Detachable Coil Type, Pushable Coil Type); Material (Platinum Material, Platinum & Hydrogel Material, Platinum Tungsten Alloy Material); Application (Bleeding & Trauma Application, Malformations Application, Tumors Application, Visceral Aneurysm Application, Other Applications)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Abbott
• Acandis GmbH
• Balt Extrusion
• BALT USA
• Boston Scientific
• Cook Medical
• Cordis
• DePuy Synthes (J&J)
• InspireMD
• Kaneka Corporation
• Medikit Co., Ltd.
• Medtronic
• Merit Medical Systems
• MicroPort Scientific
• Penumbra Inc.
• phenox GmbH
• Stryker Corporation
• Terumo Corporation
• Vesalio
• W.L. Gore & Associates

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.